Other: — Drugs: — Other
N332208 · 2023-05-10 — The tariff classification of Lenvatinib Mesylate (CAS No. 857890-39-2) in bulk powder form, from Italy
Lenvatinib Mesylate, imported in bulk powder form, is a receptor tyrosine kinase (RTK) inhibitor. It is indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer and renal cell carcinoma. The applicable subheading for the Lenvatinib Mesylate in bulk form will be 2933.49.2600, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing in the structure a quinoline or isoquinoline ring-system (whether…
N322351 · 2021-11-15 — The tariff classification of Lenvatinib Mesylate (CAS No. 857890-39-2) in bulk form, from India
Lenvatinib Mesylate, imported in 80 grams, is a receptor tyrosine kinase (RTK) inhibitor. It is indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer. The applicable subheading for the Lenvatinib Mesylate in bulk form will be 2933.49.2600, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s)only: Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further…
N312770 · 2020-07-23 — The tariff classification of Cabozantinib (CAS No. 849217-68-1) in bulk powder form, from Finland
Cabozantinib is an antineoplastic agent and a receptor tyrosine kinase inhibitor with activity against MET, VEGFR2, FLT3, c-KIT, and RET. It is indicated for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. The applicable subheading for the Cabozantinib in bulk powder form will be 2933.49.2600, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s)only: Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further…
N289453 · 2017-09-18 — The tariff classification of Besifloxacin Hydrochloride (CAS No. 405165-61-9) in bulk form, from India
Besifloxacin Hydrochloride is a fourth generation fluoroquinolone antibacterial indicated for the treatment of bacterial conjunctivitis. The applicable subheading for the Besifloxacin Hydrochloride in bulk form will be 2933.49.2600, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s)only: Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: Other: Other: Drugs: Other.” Pursuant to GN 13, HTSUS, the rate of duty will be free. Duty rates are…
N263085 · 2015-04-14 — The tariff classification of Solifenacin Succinate (CAS 242478-38-2), in bulk powder form, from Spain
The subject product, Solifenacin Succinate, is a muscarinic receptor antagonist. It is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence (UUI), urgency and urinary frequency. The applicable subheading for the Solifenacin Succinate will be 2933.49.2600, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s)only: Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: Other: Other: Drugs: Other.” Pursuant to…
Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.
Classify a product